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ABSTRACT  
Background: Chronic kidney disease (CKD) is estimated to affect up to 6% of women of 
reproductive age. Maternity care represents an opportunity for early diagnosis but there is 
limited understanding of CKD aetiology occurring in or revealed by pregnancy.  
Methods: A retrospective evaluation of renal biopsies during and after pregnancy between 
2000-2015 was undertaken. A large academic health centre pathology database was searched 
for free text pregnancy-related terms, restricted to typology code 71000 (kidney). Indications 
and findings of postpartum renal biopsies were reviewed.  
Results: 63 renal biopsy reports were identified. Of 45 biopsies performed postpartum, 34 
(75.6%) investigated persistent postpartum proteinuria. 20/34 (70.6%) of these biopsies 
yielded a primary renal disease, and 6/34 (17.6%) women had progressed to end stage renal 
disease at latest follow up.  
Conclusion: Renal biopsy findings of women investigated for persistent postpartum 
proteinuria revealed a high incidence of histological diagnosis of de novo renal disease.   
 
 
 
 
 
 
  
Introduction 
Chronic kidney disease (CKD) stages 1 to 5 are estimated to affect up to 6% of women of 
reproductive age,1 with early stage renal disease (stages 1 and 2) accounting for the majority 
of cases.1,2 Pregnancies in women with CKD are associated with higher rates of maternal and 
perinatal morbidity and mortality,3 even in those with mild disease, compared to low risk 
pregnant populations.4 Proteinuria may be the only indication of renal pathology before a 
reduction in glomerular filtration rate (GFR) and routine urine testing in pregnancy represents 
an opportunity for early diagnosis.5 
 
Ongoing proteinuria identified postpartum can be a manifestation of resolving glomerular 
impairment secondary to pre-eclampsia or primary renal disease. Data from small cohort 
studies suggests that at six months postpartum proteinuria secondary to pre-eclampsia has 
resolved in over 95% of women;6 however women with persistent proteinuria following pre-
eclampsia are reported to have high rates of underlying renal disease.7 Our objective was to 
review the indications and findings of renal biopsies performed postpartum at a large London 
hospital, and determine rates of diagnosis of new renal disease.  
 
Methods 
Data collection 
The hospital pathology database was searched using free text terms: ‘Pregnancy’, ‘pregnant’, 
‘postpartum’ and ‘post-partum’ between 2000 and 2015, with no restriction other than 
typology code 71000 (kidney). All histology reports were reviewed by FCR. Clinical 
information on indication for biopsy and maternal age was extracted from the biopsy reports, 
and final histological diagnosis recorded. Biopsy slides were reviewed by FCR and PB in 
indeterminate cases and diagnosis assigned if there was consensus.  
 
Further data extraction in subgroups with sufficient numbers (n>30) to enable meaningful 
analysis of biopsy findings and follow-up was undertaken, including serum creatinine 
concentrations and protein: creatinine ratio (PCR) values at delivery, at the time of biopsy and 
at follow up (1 year post biopsy and most recent assessment) were extracted from hospital 
laboratory records. Estimated glomerular filtration rate (eGFR) was calculated using the 
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. The work was 
registered as an audit at the local hospital site and approved by the audit committee. 
 
Renal biopsy processing 
Routine stains were performed on all renal biopsy sections (Hematoxylin and Eosin, 
Haematoxylin/van Gieson, Congo Red, Periodic Acid Schiff and Periodic acid silver 
methenamine stain) and immunohistochemistry for IgM, IgG, IgA, C9, C3 and C1q undertaken 
prior to reporting by a specialist renal histopathologist. Electron micrographic images were 
reviewed where appropriate.  
 
Results 
Sixty-three renal biopsies related to pregnancy were identified, of which 55 were eligible for 
further evaluation in the study.  Case selection is illustrated in Figure 1. The indications for all 
renal biopsies are shown in Table 1. 3.6% of biopsies were taken pre-pregnancy, 14.5% during 
pregnancy and 81.8% postpartum. Median maternal age at time of biopsy was 33 years 
(interquartile range (IQR) 29, 37).  
 Biopsies performed pre-pregnancy and during pregnancy 
There were eight biopsies performed during pregnancy between 2000-2015 including two in 
women with known systemic lupus erythematosus (SLE), with active lupus nephritis 
confirmed in both. All women had proteinuria including six with nephrotic range 
(proteinuria > 3.5g/day) urinalysis (one with SLE). In the remaining six women a variety of 
diagnoses were made: diabetic glomerulopathy, minimal change disease, fibrillary 
glomerulopathy with extensive chronic renal damage, pre-eclampsia, late IgA nephropathy, 
and in one case no diagnosis was reached. Data on gestational age at biopsy were available 
in six cases, median gestational age at the time of biopsy was 13 weeks (IQR 12-15).  
 
There were two biopsies performed specifically prior to pregnancy in women with renal 
transplants. One woman had recently switched immunosuppressive agent and was planning 
a pregnancy, and the other had deteriorating renal function with her third renal transplant 
and was planning a pregnancy. Biopsies in both cases demonstrated chronic renal allograft 
damage.  
 
Biopsies performed postpartum 
The majority (34/45; 75.6%) of postpartum renal biopsies were performed to investigate 
persistent postpartum proteinuria and further data extraction and analysis was conducted on 
this subgroup. These biopsies were performed a median of 24 months (IQR 9, 36) after 
delivery. Histological findings of biopsies investigating persistent postpartum proteinuria are 
shown in Table 2. Most biopsies (24/34; 70.5%) to investigate persistent postpartum 
proteinuria identified glomerular pathology, with hyperfiltration changes being most 
common (‘overload’ or secondary focal segmental glomerulosclerosis (FSGS) 11/34; 32.4%). 
Biopsies with ‘overload changes’ (n=8) (primary histological finding of glomerulomegaly) were 
taken at a median of 12 months (IQR 9, 48) postpartum, whereas those revealing secondary 
FSGS (n=3) (primary histological finding of segmental areas of scarring) were performed a 
median of 36 months postpartum (IQR 30, 60); whilst there was no statistically significant 
difference in biopsy timing this was limited by small numbers in each group.  
 
Renal function and progression to end stage renal disease in women with postpartum 
proteinuria 
Median eGFR was 109 ml/min/1.73m2 (IQR 69, 115), and median urinary PCR was 167 
mg/mmol (IQR 146, 219) at time of biopsy in women investigated for persistent postpartum 
proteinuria. Creatinine, eGFR and PCR at time of biopsy, 1 year post biopsy and at latest follow 
up are shown in Table 3. There were no statistically significant differences between markers 
of renal function and proteinuria at time of biopsy, 1 year post biopsy and follow-up but data 
were absent for several women due to clinical care continuing at their local hospital, and 
follow up data included women who had progressed to end stage renal disease (ESRD) and 
were receiving renal replacement therapy or a renal transplant. 
 
Six of 34 (17.6%) of women biopsied for persistent postpartum proteinuria had progressed to 
end stage renal disease (ESRD) at latest follow up. Median months between biopsy and latest 
follow up in these women was 160 (IQR 148, 181). Five had received a renal transplant and 
one woman was on dialysis. Biopsy findings included: overload changes/FSGS (n=2), primary 
FSGS (n=2), late chronic parenchymal damage (n=1), and hypertensive renal disease (n=1). 
Median eGFR at time of biopsy in women who developed ESRD compared to those who did 
not was 25 ml/min/1.73m2  (IQR 11, 91) and 113 ml/min/1.73m2 (IQR 33, 129) respectively.   
 
Discussion 
Principal findings 
Renal biopsy findings of women being investigated for persistent postpartum proteinuria 
revealed a high incidence of histological diagnosis of de novo renal disease with high rates of 
progression to ESRD (almost one in five women).  Women who had progressed to ESRD at 
latest follow up had worse renal function at time of biopsy. Overload changes tended to be 
evident in biopsies performed sooner after delivery whereas FSGS lesions were more 
common in delayed biopsies which may indicate a histological transition from 
hyperfiltration to scarring.  The number of renal biopsies conducted before, during or after 
pregnancy was small.  
 
Study strengths and limitations 
There are few studies reporting biopsies performed to investigate renal disease identified 
during or after pregnancy. This study investigating fifteen years of biopsy reports enhances 
our understanding of pregnancy as an opportunity to unmask CKD. Whilst renal biopsy reports 
represent the most severe end of the diagnostic spectrum, the relatively small number of 
reports identified in this study may indicate that kidney disease may not be easily recognised 
during pregnancy, is not always actively investigated, or is mild and does not meet criteria to 
recommend biopsy. It is likely that more severe disease is presented in this study i.e. those 
biopsied. However, the proportion of women with postpartum proteinuria who progressed 
to ESRD highlights the need for focussed care for this high-risk group. 
 The association between biopsies taken closer to pregnancy revealing ‘overload’ changes and 
later biopsies showing established FSGS scarring is suggestive that there may be a window of 
opportunity to minimise hyperfiltration injury.  However, serial biopsies were not undertaken, 
nor would be clinically justified. Furthermore, clinical data including pregnancy outcomes, 
ongoing medication (e.g. Angiotensin converting enzyme inhibitors) and some follow-up data 
were not available due to transfer of care to different units and limited longitudinal 
assessment of glomerular filtration rate.  A comprehensive prospective study to explore 
natural history of postpartum proteinuria secondary to hyperfiltration injury with complete 
follow-up data would enhance understanding of the contribution of maternal risk factors and 
pregnancy-related complications including pre-eclampsia and acute kidney injury to 
persistent and progressive renal pathology. 
 
A limitation of this study was the retrospective study design; however the findings of this 
study highlight that performing a renal biopsy before, during or after pregnancy is 
uncommon.  This approach enabled several years of data to be included which could not be 
easily achieved with prospective design. 
 
Comparison to other studies 
The high incidence of histological de novo renal diagnoses in our study is consistent with a 
published multicenter series of 75 women who had postpartum biopsies for renal disease 
identified in pregnancy. Two thirds of women (68%) had a primary renal disease, with FSGS 
also being the most common diagnosis.8 Whether cases were of secondary as opposed to 
primary FSGS was not specified in this study, and can be difficult to distinguish histologically. 
A high rate of progression to ESRD in 7/47 cases (15%) where follow-up data were available 
at a median of 51.5 months (range 1-212) was also reported. Similarly, FSGS was identified 
in a third of women in a larger study of 173 pregnancy-related biopsies (11% antenatal, 89% 
up to 1 year postpartum) and 12.7% required renal replacement therapy in the follow up 
period (median follow up 42.8 months (IQR 17.4, 70.9)).9 In a retrospective study of women 
with glomerulopathies who had a pregnancy prior to their diagnosis, those who reported 
deterioration of renal function, worsening proteinuria, worsening blood pressure control 
and/or pre-eclampsia diagnosis during pregnancy were diagnosed with glomerulopathy 
sooner than women who had reported an uncomplicated pregnancy.10 Together with our 
findings these studies suggest that pregnancy or delivery may exacerbate or cause 
hyperfiltration injury, and reveals otherwise undiagnosed renal disease. 
 
Summary, implications for clinical practice and future research  
The findings of this study confirm that renal biopsy postpartum can reveal renal pathology 
which may pre-exist or develop during pregnancy, with a high rate of progression to ESRD in 
these young women. Currently NICE guidelines on management of Hypertension in 
pregnancy11 recommend referral of women to a specialist for investigation if they have 
persistent dipstick proteinuria >2+ protein at 6 weeks postpartum following hypertensive 
disorders of pregnancy. Clinicians caring for women in pregnancy should liaise with Primary 
Care clinicians to ensure that women who are proteinuric in pregnancy (for example those 
that developed a hypertensive disorder of pregnancy or gestational proteinuria) have repeat 
urinalysis with quantification of proteinuria if appropriate at the six week postnatal check. 
Those with persistent proteinuria should be followed up and investigated, and referred to 
Nephrology services in keeping with the NICE guidelineswomen that have persistent 
proteinuria postpartum have appropriate follow-up and are investigated appropriately.   
 
Currently NICE guidelines on management of Hypertension in pregnancy11 recommend 
referral of women to a specialist for investigation if they have persistent dipstick proteinuria 
>2+ protein at 6 weeks postpartum following hypertensive disorders of pregnancy. Larger 
prospective studies are required to evaluate the incidence of new CKD diagnoses following 
investigation of persistent postpartum proteinuria, disease course and strategies to slow 
progression especially in those with early features of hyperfiltration. 
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